NATCOPHARM

921.45001 INR
16.25
1.80%
Last update Dec 16, 3:29 PM IST
Market closed
Day range
903.20001
928.20001
Previous close
905.20001
Open
905.25
Access this stock data via API
Subscribe
Natco Pharma Ltd.
921.45
16.25
1.80%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 13.6B 13.3B 12.0B 4.7B
Cost of revenue 1.7B 2.3B 4.2B 828M
Gross profit 11.9B 11.0B 7.8B 3.9B
Operating expense
Research & development
Selling general and admin
Other operating expenses 4.1B 3.6B -3.6B 2.1B
Operating income 5.3B 5.1B 4.7B -82M
Non operating interest income
Income
Expense 131M 32M 33M 44M
Other income expense
Pretax income 6.1B 5.7B 5.1B 1.6B
Tax provision 958M 916M 999M 313M
Net income 5.2B 4.8B 4.1B 1.3B
Basic EPS 28.9 26.8 7.4
Diluted EPS 28.9 26.8 7.4
Basic average shares 179.1M 179.1M 179.0M
Diluted average shares 179.1M 179.1M 179.0M
EBITDA 6.8B 6.3B 6.1B 2.2B
Net income from continuing op.
Minority interests 5M 4M 6M 6M
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 2 hours 39 minutes

06:35
00:00
09:15
15:30
23:59

Trading Hours (Sunday - Thursday):

Main market
09:15 - 15:30
All times are displayed in the Asia/Kolkata timezone (IST, UTC+05:30).